| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Feld Michael | EVP, Chief Revenue Officer | C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES | Donna Kalazdy, by power of attorney from Michael Feld | 27 Feb 2026 | 0002034349 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Common Stock | Sale | $13,638 | -75 | -0.35% | $181.84 | 21,308 | 26 Feb 2026 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 7, 2025.